2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
8
Melanoma
6
Colitis, Ulcerative
6
Inflammatory Bowel Diseases
5
Crohn Disease
5
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Colitis
3
Urogenital Neoplasms
2
Inflammation
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Fatigue
2
Depressive Disorder, Major
2
Depression
2
Cachexia
2
Anorexia
2
Vasculitis
1
Takayasu Arteritis
1
Syndrome
1
Stroke
1
Stevens-Johnson Syndrome
1
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Recurrence
1
Rare Diseases
1
Psoriasis
1
Precancerous Conditions
1
Pemphigoid, Benign Mucous Membrane
1
Pancreatic Neoplasms
1
Interventions
ziprasidone
1
drospirenone
1
Zolpidem
1
Warfarin
1
Venlafaxine Hydrochloride
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Surveys and Questionnaires
1
Spironolactone
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Metformin
1
Medical Marijuana
1
Lurasidone Hydrochloride
1
Labetalol
1
Infliximab
1
Haloperidol
1
Gabapentin
1
Fosfomycin
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bipolar Disorder
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts